Now
Approved

Not an actual patient or healthcare provider.

Now
Approved

What is MONJUVI?

MONJUVI is a prescription medicine given with lenalidomide to treat adults with certain types of diffuse large B-cell lymphoma (DLBCL) that has come back (relapsed) or that did not respond to previous treatment (refractory) and who cannot receive a stem cell transplant.

What to expect from treatment with MONJUVI

You and your healthcare team may be considering whether to begin your treatment with MONJUVI. Or, you may be seeking more information about MONJUVI for yourself or a loved one.

This website provides important information about what to expect during treatment with MONJUVI. It includes details about how you can receive MONJUVI, the side effects you may experience, and support options for you during your treatment.

Learn more about how you will receive MONJUVI and your treatment schedule.

EXPAND